IP Library Granted Patent US 8,940,512
Granted Patent B2
US 8,940,512 · App. 13/151,876 · Granted Jan 27, 2015

Processes for synthesizing alkaline phosphatase conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,512
App. No.
13/151,876
Granted
Jan 27, 2015
Kind
B2
Abstract

Methods for synthesizing an ALP conjugate are provided. The methods may include activating a carboxyl group of the ALP with a carbodiimide, to generate an active ester; and adding the substance to be conjugated such that a synthetic reaction occurs between the active ester and the substance to be conjugated, to generate an ALP conjugate.

Claims (17)

1. A method of synthesizing an alkaline phosphatase (“ALP”) conjugate, comprising:

activating a carbonyl group of ALP with a carbodiimide under acidic conditions to form an active ALP ester; and

adding a substance to be conjugated under basic conditions; wherein the active ALP ester reacts with the substance to be conjugated to generate an ALP conjugate.

2. The method of claim 1 , wherein activating of a carbonyl group further comprises adding a hydroxysuccinimide.

3. The method of claim 1 , wherein the substance to be conjugated is selected from at least one of the following: a peptide, a protein, an antigen, an antibody, and Staphylococcus protein A.

4. The method of claim 1 , wherein the acidic conditions range between about pH 4.0 and about pH 5.0.

5. The method of claim 1 , wherein the carbodiimide is selected from at least one of the following: dicyclohexylcarbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC), and N,N′-diisopropylcarbodiimide (DIC).

6. The method of claim 2 , wherein the hydroxysuccinimide is selected from at least one of the following: N-hydroxysuccinimide (NHS) and sulfo-N hydroxysuccinimide (sulfo-NHS).

7. The method of claim 1 , wherein the basic conditions range between about pH 7.5 and about pH 9.0.

8. The method of claim 1 , further comprising purifying the ALP conjugate.

9. The method of claim 8 , wherein purifying the ALP conjugate comprises using at least one of the following for purification: ultrafiltration, a desalting column, dialysis, gel filtration, Protein A or G affinity column chromatography, and ammonium sulfate precipitation.

10. A method of synthesizing an enzyme conjugate, comprising:

activating a carbonyl group of an enzyme with a carbodiimide, under acidic conditions between about pH 4.0 and about pH 5.0, to form an active ester; and

adding a substance to be conjugated selected from at least one of the following: a peptide, a protein, an antigen, an antibody, and Staphylococcus protein A, under basic conditions between about pH 7.5 and about pH 9.0;

wherein the active ester reacts with the substance to be conjugated to generate an enzyme conjugate.

11. The method of claim 10 , wherein activating of a carbonyl group further comprises adding a hydroxysuccinimide.

12. The method of claim 11 , wherein the carbodiimide is selected from at least one of the following: dicyclohexylcarbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC), and N,N′-diisopropylcarbodiimide (DIC); and wherein the hydroxysuccinimide is selected from at least one of the following: N-hydroxysuccinimide (NHS) and sulfo-N-hydroxysuccinimide (sulfo-NHS).

Assignments (2)
LICENSE Recorded Jun 24, 2022
From: SHENZHEN MINDRAY BIOMEDICAL ELECTRONICS CO., LTD.
To: SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
Reel/Frame 060440/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2011
From: QIAN, CHUNGEN; LI, KE; ZHANG, YUPING
To: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Reel/Frame 026381/0974 →